(Total Views: 307)
Posted On: 02/04/2021 11:15:36 AM
Post# of 36542
Before details of the NGIO IPO and pre-clinical trials are made public Joe is careful to not provide any information that could be a concern.
OTOH, you would have to be pretty obtuse to have missed the nuggets he has left the last couple of months. Of course, I see things in the dark that are not really there sometimes. Perhaps I am mistaken.
OTOH, you would have to be pretty obtuse to have missed the nuggets he has left the last couple of months. Of course, I see things in the dark that are not really there sometimes. Perhaps I am mistaken.
(3)
(0)Scroll down for more posts ▼
